ヒト免疫グロブリンの世界市場、2024年～2028年

ヒト免疫グロブリン市場は2023-2028年に96億9,600万米ドル、予測期間中のCAGRは10.11%で成長すると予測されます。

当レポートでは、ヒト免疫グロブリン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。血漿提供の増加、免疫不全疾患の有病率の上昇、老年人口の増加が市場を牽引しています。

本調査では、今後数年間のヒト免疫グロブリン市場成長を牽引する主な要因の1つとして、ヒト免疫グロブリンの研究開発の高まりを挙げています。また、ヒト免疫グロブリンに関する規制認可の増加や、ヒト免疫グロブリンの製造における製造技術の進歩は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 Technavio別分析

• 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
• インプットの重要性と差別化の要因
• 混乱の要因
• 促進要因と課題の影響

第3章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第4章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第5章 市場規模実績

• ヒト免疫グロブリンの世界市場 2018-2022
• 用途別セグメント分析 2018-2022
• エンドユーザー別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第6章 定性分析

• AIの影響：ヒト免疫グロブリンの世界市場

第7章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第8章 市場セグメンテーション：用途別

• 市場セグメンテーション
• 比較：用途別
• 自己免疫疾患：市場規模と予測 2023-2028
• 血液疾患：市場規模と予測 2023-2028
• 炎症性疾患：市場規模と予測 2023-2028
• 感染症：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：用途別

第9章 市場セグメンテーション：エンドユーザー別

• 市場セグメンテーション
• 比較：エンドユーザー別
• 病院：市場規模と予測 2023-2028
• クリニック：市場規模と予測 2023-2028
• 外来手術センター（ASC）：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第10章 顧客情勢

• 顧客情勢の概要

第11章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• スペイン：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 韓国：市場規模と予測 2023-2028
• ブラジル：市場規模と予測 2023-2028
• インド：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第12章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第13章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第14章 競合分析

• 企業プロファイル
• 企業ランキング指数
• 企業の市場ポジショニング
• ADMA Biologics Inc.
• Baxter International Inc.
• Bio Products Laboratory Ltd.
• CSL Ltd.
• Emergent BioSolutions Inc.
• Grifols SA
• Hualan Biological Vaccine Inc.
• Kamada Ltd.
• Kedrion Spa
• LFB SA
• Octapharma AG
• Pfizer Inc.
• Prothya Biosolutions Netherlands BV
• Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
• Takeda Pharmaceutical Co. Ltd.

第15章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits11: Overview on criticality of inputs and factors of differentiation
• Exhibits12: Overview on factors of disruption
• Exhibits13: Impact of drivers and challenges in 2023 and 2028
• Exhibits14: Parent Market
• Exhibits15: Data Table on - Parent Market
• Exhibits16: Market characteristics analysis
• Exhibits17: Value Chain Analysis
• Exhibits18: Offerings of companies included in the market definition
• Exhibits19: Market segments
• Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits24: Historic Market Size - Data Table on Global Human Immunoglobulin Market 2018 - 2022 ($ million)
• Exhibits25: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• Exhibits26: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits29: Five forces analysis - Comparison between 2023 and 2028
• Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits35: Chart on Market condition - Five forces 2023 and 2028
• Exhibits36: Chart on Application - Market share 2023-2028 (%)
• Exhibits37: Data Table on Application - Market share 2023-2028 (%)
• Exhibits38: Chart on Comparison by Application
• Exhibits39: Data Table on Comparison by Application
• Exhibits40: Chart on Autoimmune disorders - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Autoimmune disorders - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
• Exhibits44: Chart on Hematology diseases - Market size and forecast 2023-2028 ($ million)
• Exhibits45: Data Table on Hematology diseases - Market size and forecast 2023-2028 ($ million)
• Exhibits46: Chart on Hematology diseases - Year-over-year growth 2023-2028 (%)
• Exhibits47: Data Table on Hematology diseases - Year-over-year growth 2023-2028 (%)
• Exhibits48: Chart on Inflammatory diseases - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on Inflammatory diseases - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on Inflammatory diseases - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Inflammatory diseases - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by Application ($ million)
• Exhibits61: Data Table on Market opportunity by Application ($ million)
• Exhibits62: Chart on End-user - Market share 2023-2028 (%)
• Exhibits63: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits64: Chart on Comparison by End-user
• Exhibits65: Data Table on Comparison by End-user
• Exhibits66: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits69: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits70: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Chart on Clinics - Year-over-year growth 2023-2028 (%)
• Exhibits73: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
• Exhibits74: Chart on Ambulatory surgical center (ASC) - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Data Table on Ambulatory surgical center (ASC) - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Chart on Ambulatory surgical center (ASC) - Year-over-year growth 2023-2028 (%)
• Exhibits77: Data Table on Ambulatory surgical center (ASC) - Year-over-year growth 2023-2028 (%)
• Exhibits78: Market opportunity by End-user ($ million)
• Exhibits79: Data Table on Market opportunity by End-user ($ million)
• Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits83: Chart on Geographic comparison
• Exhibits84: Data Table on Geographic comparison
• Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits109: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits110: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits111: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits112: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits113: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits115: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits116: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits117: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits118: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits119: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits120: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits121: Chart on Spain - Market size and forecast 2023-2028 ($ million)
• Exhibits122: Data Table on Spain - Market size and forecast 2023-2028 ($ million)
• Exhibits123: Chart on Spain - Year-over-year growth 2023-2028 (%)
• Exhibits124: Data Table on Spain - Year-over-year growth 2023-2028 (%)
• Exhibits125: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits126: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits127: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits128: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits129: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
• Exhibits130: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
• Exhibits131: Chart on South Korea - Year-over-year growth 2023-2028 (%)
• Exhibits132: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
• Exhibits133: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
• Exhibits134: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
• Exhibits135: Chart on Brazil - Year-over-year growth 2023-2028 (%)
• Exhibits136: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• Exhibits137: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits138: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits139: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits140: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits141: Market opportunity By Geographical Landscape ($ million)
• Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits143: Impact of drivers and challenges in 2023 and 2028
• Exhibits144: Overview on criticality of inputs and factors of differentiation
• Exhibits145: Overview on factors of disruption
• Exhibits146: Impact of key risks on business
• Exhibits147: Companies covered
• Exhibits148: Company ranking index
• Exhibits149: Matrix on companies position and classification
• Exhibits150: ADMA Biologics Inc. - Overview
• Exhibits151: ADMA Biologics Inc. - Business segments
• Exhibits152: ADMA Biologics Inc. - Key news
• Exhibits153: ADMA Biologics Inc. - Key offerings
• Exhibits154: ADMA Biologics Inc. - Segment focus
• Exhibits155: SWOT
• Exhibits156: Baxter International Inc. - Overview
• Exhibits157: Baxter International Inc. - Business segments
• Exhibits158: Baxter International Inc. - Key news
• Exhibits159: Baxter International Inc. - Key offerings
• Exhibits160: Baxter International Inc. - Segment focus
• Exhibits161: SWOT
• Exhibits162: Bio Products Laboratory Ltd. - Overview
• Exhibits163: Bio Products Laboratory Ltd. - Product / Service
• Exhibits164: Bio Products Laboratory Ltd. - Key offerings
• Exhibits165: SWOT
• Exhibits166: CSL Ltd. - Overview
• Exhibits167: CSL Ltd. - Business segments
• Exhibits168: CSL Ltd. - Key news
• Exhibits169: CSL Ltd. - Key offerings
• Exhibits170: CSL Ltd. - Segment focus
• Exhibits171: SWOT
• Exhibits172: Emergent BioSolutions Inc. - Overview
• Exhibits173: Emergent BioSolutions Inc. - Product / Service
• Exhibits174: Emergent BioSolutions Inc. - Key offerings
• Exhibits175: SWOT
• Exhibits176: Grifols SA - Overview
• Exhibits177: Grifols SA - Business segments
• Exhibits178: Grifols SA - Key news
• Exhibits179: Grifols SA - Key offerings
• Exhibits180: Grifols SA - Segment focus
• Exhibits181: SWOT
• Exhibits182: Hualan Biological Vaccine Inc. - Overview
• Exhibits183: Hualan Biological Vaccine Inc. - Product / Service
• Exhibits184: Hualan Biological Vaccine Inc. - Key offerings
• Exhibits185: SWOT
• Exhibits186: Kamada Ltd. - Overview
• Exhibits187: Kamada Ltd. - Business segments
• Exhibits188: Kamada Ltd. - Key offerings
• Exhibits189: Kamada Ltd. - Segment focus
• Exhibits190: SWOT
• Exhibits191: Kedrion Spa - Overview
• Exhibits192: Kedrion Spa - Product / Service
• Exhibits193: Kedrion Spa - Key offerings
• Exhibits194: SWOT
• Exhibits195: LFB SA - Overview
• Exhibits196: LFB SA - Product / Service
• Exhibits197: LFB SA - Key offerings
• Exhibits198: SWOT
• Exhibits199: Octapharma AG - Overview
• Exhibits200: Octapharma AG - Product / Service
• Exhibits201: Octapharma AG - Key offerings
• Exhibits202: SWOT
• Exhibits203: Pfizer Inc. - Overview
• Exhibits204: Pfizer Inc. - Product / Service
• Exhibits205: Pfizer Inc. - Key news
• Exhibits206: Pfizer Inc. - Key offerings
• Exhibits207: SWOT
• Exhibits208: Prothya Biosolutions Netherlands BV - Overview
• Exhibits209: Prothya Biosolutions Netherlands BV - Product / Service
• Exhibits210: Prothya Biosolutions Netherlands BV - Key offerings
• Exhibits211: SWOT
• Exhibits212: Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Overview
• Exhibits213: Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Product / Service
• Exhibits214: Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Key offerings
• Exhibits215: SWOT
• Exhibits216: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits217: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits218: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits219: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits220: SWOT
• Exhibits221: Inclusions checklist
• Exhibits222: Exclusions checklist
• Exhibits223: Currency conversion rates for US$
• Exhibits224: Research methodology
• Exhibits225: Information sources
• Exhibits226: Data validation
• Exhibits227: Validation techniques employed for market sizing
• Exhibits228: Data synthesis
• Exhibits229: 360 degree market analysis
• Exhibits230: List of abbreviations

The human immunoglobulin market is forecasted to grow by USD 9696 mn during 2023-2028, accelerating at a CAGR of 10.11% during the forecast period. The report on the human immunoglobulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in plasma donation, rising prevalence of immunodeficiency disorders, and growing geriatric population.

Technavio's human immunoglobulin market is segmented as below:

By Application

• Autoimmune disorders
• Hematology diseases
• Inflammatory diseases
• Infectious diseases
• Others

By End-user

• Hospitals
• Clinics
• Ambulatory surgical center (ASC)

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising research and development in human immunoglobulin as one of the prime reasons driving the human immunoglobulin market growth during the next few years. Also, growing regulatory approvals on human immunoglobulin and advancements in manufacturing technologies in production of human immunoglobulin will lead to sizable demand in the market.

The report on the human immunoglobulin market covers the following areas:

• Human immunoglobulin market sizing
• Human immunoglobulin market forecast
• Human immunoglobulin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunoglobulin market vendors that include ADMA Biologics Inc., argenx SE, Baxter International Inc., Bio Products Laboratory Ltd., CSL Ltd., Emergent BioSolutions Inc., Grifols SA, Hualan Biological Vaccine Inc., Kamada Ltd., Kedrion Spa, LFB SA, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, Sanquin, Shanghai RAAS Blood Products Co. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, and Takeda Pharmaceutical Co. Ltd.. Also, the human immunoglobulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Human Immunoglobulin Market 2018 - 2022
  • Historic Market Size - Data Table on Global Human Immunoglobulin Market 2018 - 2022 ($ million)
• 5.2 Application segment analysis 2018 - 2022
  • Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 5.3 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Human Immunoglobulin Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Application

• 8.1 Market segments
  • Chart on Application - Market share 2023-2028 (%)
  • Data Table on Application - Market share 2023-2028 (%)
• 8.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 8.3 Autoimmune disorders - Market size and forecast 2023-2028
  • Chart on Autoimmune disorders - Market size and forecast 2023-2028 ($ million)
  • Data Table on Autoimmune disorders - Market size and forecast 2023-2028 ($ million)
  • Chart on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
  • Data Table on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
• 8.4 Hematology diseases - Market size and forecast 2023-2028
  • Chart on Hematology diseases - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hematology diseases - Market size and forecast 2023-2028 ($ million)
  • Chart on Hematology diseases - Year-over-year growth 2023-2028 (%)
  • Data Table on Hematology diseases - Year-over-year growth 2023-2028 (%)
• 8.5 Inflammatory diseases - Market size and forecast 2023-2028
  • Chart on Inflammatory diseases - Market size and forecast 2023-2028 ($ million)
  • Data Table on Inflammatory diseases - Market size and forecast 2023-2028 ($ million)
  • Chart on Inflammatory diseases - Year-over-year growth 2023-2028 (%)
  • Data Table on Inflammatory diseases - Year-over-year growth 2023-2028 (%)
• 8.6 Infectious diseases - Market size and forecast 2023-2028
  • Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
  • Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
  • Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
  • Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
• 8.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 8.8 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2023-2028
  • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 9.4 Clinics - Market size and forecast 2023-2028
  • Chart on Clinics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
  • Chart on Clinics - Year-over-year growth 2023-2028 (%)
  • Data Table on Clinics - Year-over-year growth 2023-2028 (%)
• 9.5 Ambulatory surgical center (ASC) - Market size and forecast 2023-2028
  • Chart on Ambulatory surgical center (ASC) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ambulatory surgical center (ASC) - Market size and forecast 2023-2028 ($ million)
  • Chart on Ambulatory surgical center (ASC) - Year-over-year growth 2023-2028 (%)
  • Data Table on Ambulatory surgical center (ASC) - Year-over-year growth 2023-2028 (%)
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 11.9 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 11.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 11.11 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 11.12 Spain - Market size and forecast 2023-2028
  • Chart on Spain - Market size and forecast 2023-2028 ($ million)
  • Data Table on Spain - Market size and forecast 2023-2028 ($ million)
  • Chart on Spain - Year-over-year growth 2023-2028 (%)
  • Data Table on Spain - Year-over-year growth 2023-2028 (%)
• 11.13 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 11.14 South Korea - Market size and forecast 2023-2028
  • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
• 11.15 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 11.16 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 ADMA Biologics Inc.
  • ADMA Biologics Inc. - Overview
  • ADMA Biologics Inc. - Business segments
  • ADMA Biologics Inc. - Key news
  • ADMA Biologics Inc. - Key offerings
  • ADMA Biologics Inc. - Segment focus
  • SWOT
• 14.5 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 14.6 Bio Products Laboratory Ltd.
  • Bio Products Laboratory Ltd. - Overview
  • Bio Products Laboratory Ltd. - Product / Service
  • Bio Products Laboratory Ltd. - Key offerings
  • SWOT
• 14.7 CSL Ltd.
  • CSL Ltd. - Overview
  • CSL Ltd. - Business segments
  • CSL Ltd. - Key news
  • CSL Ltd. - Key offerings
  • CSL Ltd. - Segment focus
  • SWOT
• 14.8 Emergent BioSolutions Inc.
  • Emergent BioSolutions Inc. - Overview
  • Emergent BioSolutions Inc. - Product / Service
  • Emergent BioSolutions Inc. - Key offerings
  • SWOT
• 14.9 Grifols SA
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key news
  • Grifols SA - Key offerings
  • Grifols SA - Segment focus
  • SWOT
• 14.10 Hualan Biological Vaccine Inc.
  • Hualan Biological Vaccine Inc. - Overview
  • Hualan Biological Vaccine Inc. - Product / Service
  • Hualan Biological Vaccine Inc. - Key offerings
  • SWOT
• 14.11 Kamada Ltd.
  • Kamada Ltd. - Overview
  • Kamada Ltd. - Business segments
  • Kamada Ltd. - Key offerings
  • Kamada Ltd. - Segment focus
  • SWOT
• 14.12 Kedrion Spa
  • Kedrion Spa - Overview
  • Kedrion Spa - Product / Service
  • Kedrion Spa - Key offerings
  • SWOT
• 14.13 LFB SA
  • LFB SA - Overview
  • LFB SA - Product / Service
  • LFB SA - Key offerings
  • SWOT
• 14.14 Octapharma AG
  • Octapharma AG - Overview
  • Octapharma AG - Product / Service
  • Octapharma AG - Key offerings
  • SWOT
• 14.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 14.16 Prothya Biosolutions Netherlands BV
  • Prothya Biosolutions Netherlands BV - Overview
  • Prothya Biosolutions Netherlands BV - Product / Service
  • Prothya Biosolutions Netherlands BV - Key offerings
  • SWOT
• 14.17 Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
  • Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Overview
  • Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Product / Service
  • Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Key offerings
  • SWOT
• 14.18 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations